Unless otherwise noted, all growth rates in this Release refer to same period in prior year. 2. Please see detailed guidance ...
Coartem Baby was developed by Novartis with the scientific and financial support of MMV, and as part of the PAMAfrica ...
Novartis works with the patient community around the world to discover new ways to improve and extend people’s lives. Novartis works closely with healthcare professionals around the world to support ...
studies were published in Nature Medicine. Following the CHMP’s recommendation for approval, the European Commission (EC) is expected to issue a final decision within approximately two months. About ...
We are an innovative medicines company with research and development at our core. Our R&D engine powers an industry-leading pipeline focused on delivering transformative medicines to fight disease, ...
Explore opportunities with Novartis and Sandoz below. For additional roles with Novartis Gene Therapies (formerly AveXis) visit the GTx Career Search.
Novartis works closely with healthcare professionals around the work to support their treatment of patients and collaborate on unmet needs. Novartis works with healthcare professionals (HCPs) to ...
～2歳未満を対象としたゾルゲンスマ ® 点滴静注に次ぐ、SMAの新たな治療選択肢～ ノバルティス ファーマ株式会社（本社：東京都港区、代表取締役社長：ジョンポール・プリシーノ、以下 ...
Scales program footprint from 11 countries to more than 30 by 2030, including across five cities in the U.S. Builds on pilot programs that demonstrated significant increase in control rates for high ...
本資料は、ノバルティス（スイス・バーゼル）が2026年3月20日（現地時間）に発表したものを日本語に翻訳したもので、参考資料として提供するものです。資料の内容および解釈については ...
Policies and positions As part of our ongoing commitment to transparency, we publish our positions on various issues affecting our business. We are also transparent about our values and behaviors, our ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results